Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies

Maju Mathews,1 Srihari Gopal,2 Arun Singh,3 Isaac Nuamah,4 Katalin Pungor,5 Wilson Tan,6 Bernardo Soares,7 Edward Kim,8 Adam J Savitz2 1Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, USA; 2Department of Neuroscience, Janssen Research & Development, LLC,...

Full description

Bibliographic Details
Main Authors: Mathews M, Gopal S, Singh A, Nuamah I, Pungor K, Tan W, Soares B, Kim E, Savitz AJ
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
long-acting injectables
relapse prevention
schizophrenia
oral paliperidone extended release
paliperidone palmitate once monthly
paliperidone palmitate three monthly
Online Access:https://www.dovepress.com/comparison-of-relapse-prevention-with-3-different-paliperidone-formula-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/comparison-of-relapse-prevention-with-3-different-paliperidone-formula-peer-reviewed-article-NDT

Similar Items